MGC Diagnostics Corporation
MGCD
MGCD was delisted on the 28th of December, 2017.
19 hedge funds and large institutions have $7.78M invested in MGC Diagnostics Corporation in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
14% less funds holding
Funds holding: 22 → 19 (-3)
35% less capital invested
Capital invested by funds: $11.9M → $7.78M (-$4.16M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$1.08M |
| 2 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$110K |
| 3 |
Renaissance Technologies
New York
|
+$94.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.5K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$34.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$1.27M |
| 2 |
PM
Penbrook Management
New York
|
-$741K |
| 3 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$590K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$207K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$83.3K |
MGCD Hedge Fund Activity: Q2 2014 in Review
19 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q2 2014, worth a combined $7.78M — down 35% from $11.9M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MGCD and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 8 added.
The largest buyer was Perceptive Advisors, adding an estimated $1.08M. The largest seller was Cadence Capital Management, exiting entirely with an estimated $1.27M sold.
- 19 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q2 2014, down from 22 in Q1 2014.
- Funds reported $7.78M of MGC Diagnostics Corporation stock for Q2 2014, down 35% quarter-over-quarter.
- 3 funds opened new MGC Diagnostics Corporation positions in Q2 2014 and 6 closed out, a net change of -3 holders.
- The largest MGC Diagnostics Corporation buyer in Q2 2014 was Perceptive Advisors, an estimated $1.08M added.
- The largest MGC Diagnostics Corporation seller in Q2 2014 was Cadence Capital Management, an estimated $1.27M sold.
Based on aggregated 13F filings for Q2 2014.